Twin Focus Capital Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,269
Closed -$354K 228
2023
Q1
$354K Hold
4,269
0.07% 141
2022
Q4
$366K Sell
4,269
-28
-0.7% -$2.22K 0.08% 128
2022
Q3
$265K Hold
4,297
0.06% 161
2022
Q2
$266K Sell
4,297
-19
-0.4% -$1.18K 0.06% 160
2022
Q1
$257K Buy
4,316
+99
+2% +$6.33K 0.05% 182
2021
Q4
$306K Buy
4,217
+811
+24% +$55.9K 0.06% 164
2021
Q3
$238K Buy
3,406
+8
+0.2% +$562 0.06% 158
2021
Q2
$234K Buy
3,398
+132
+4% +$8.81K 0.05% 168
2021
Q1
$211K Buy
+3,266
New +$211K 0.06% 144
2020
Q4
Sell
-6,535
Closed -$413K 167
2020
Q3
$413K Buy
6,535
+16
+0.2% +$1.11K 0.15% 81
2020
Q2
$502K Sell
6,519
-18
-0.3% -$1.38K 0.2% 68
2020
Q1
$489K Buy
6,537
+137
+2% +$9.47K 0.23% 68
2019
Q4
$416K Buy
6,400
+3,200
+100% +$208K 0.13% 114
2019
Q3
$203K Sell
3,200
-500
-14% -$32.7K 0.08% 151
2019
Q2
$250K Buy
+3,700
New +$243K 0.11% 112
2015
Q3
Sell
-1,711
Closed -$200K 88
2015
Q2
$200K Buy
+1,711
New +$187K 0.23% 83

Other funds holding GILD

Twin Focus Capital Partners's GILD Position: Q2 2023 in Review

Twin Focus Capital Partners sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 4,269 shares — an estimated $354K sold.

Twin Focus Capital Partners first reported a position in GILD in Q2 2015 and held it in 16 quarters. The position peaked at $502K in Q2 2020. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • Twin Focus Capital Partners reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
  • Twin Focus Capital Partners sold 4,269 Gilead Sciences shares in Q2 2023, an estimated $354K.
  • Twin Focus Capital Partners first reported a position in Gilead Sciences in Q2 2015 and held it in 16 quarters.
  • Twin Focus Capital Partners's Gilead Sciences position peaked at $502K in Q2 2020.
  • 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Twin Focus Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.